Alnylam Pharmaceuticals is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics. Its research applies RNAi, a biological process that can reduce the expression of selected genes, to develop medicines for rare and more prevalent diseases. The company’s work includes research and development, clinical programs, and commercial medicines based on this approach. Alnylam provides information about its science, pipeline, products, and patient resources on its website. Product indications, safety information, and availability vary, so patients and clinicians should consult current official prescribing information.
Claim this company profile
Please sign in to claim this profile.
Company reviews
No approved reviews yet.
Please sign in to write a review. One review per account and company.